Table 11.

Pearson correlation coefficient comparing gEUD and TCP for prostate target volumes. The selected DVH metrics were ${\mathrm{D}}_{98},{\mathrm{D}}_2$, and ${\mathrm{D}}_{50}$

			Cheung/King Parameters			Okunieff Parameters			Levegrun Parameters
		gEUD	TCP Poiss	TCP Sigm	TCP Niem	TCP Poiss	TCP Sigm	TCP Niem	TCP Poiss	TCP Sigm	TCP Niem
		High‐risk Prostate
${\mathrm{D}}_{98}$	M3D	0.582	0.599	0.527	0.581	0.593	0.516	0.581	0.595	0.579	0.579
	CC	0.335	0.396	0.254	0.336	0.393	0.242	0.337	0.394	0.338	0.340
	CR	0.339	0.469	0.242	0.344	0.471	0.227	0.346	0.470	0.353	0.356
${\mathrm{D}}_2$	M3D	0.847	0.721	0.799	0.841	0.704	0.786	0.838	0.709	0.823	0.818
	CC	0.368	0.063	0.348	0.358	0.046	0.337	0.354	0.051	0.340	0.327
	CR	0.752	0.630	0.650	0.747	0.614	0.627	0.745	0.619	0.732	0.727
${\mathrm{D}}_{50}$	M3D	0.917	0.889	0.863	0.916	0.879	0.852	0.916	0.882	0.913	0.912
	CC	0.783	0.886	0.645	0.786	0.880	0.624	0.787	0.882	0.788	0.793
	CR	0.883	0.835	0.736	0.880	0.817	0.708	0.880	0.823	0.869	0.868
		Intermediate‐risk Prostate
${\mathrm{D}}_{98}$	M3D	0.593	0.596	0.574	0.590	0.596	0.529	0.591	0.597	0.589	0.589
	CC	0.476	0.664	0.389	0.486	0.662	0.211	0.481	0.667	0.480	0.489
	CR	0.246	0.463	0.220	0.276	0.464	0.074	0.260	0.461	0.280	0.287
${\mathrm{D}}_2$	M3D	0.749	0.752	0.694	0.734	0.750	0.593	0.741	0.753	0.731	0.729
	CC	0.409	0.370	0.352	0.406	0.367	0.230	0.408	0.373	0.405	0.404
	CR	0.662	0.651	0.582	0.655	0.648	0.364	0.659	0.655	0.653	0.652
${\mathrm{D}}_{50}$	M3D	0.846	0.877	0.811	0.843	0.877	0.724	0.845	0.878	0.842	0.842
	CC	0.641	0.863	0.536	0.656	0.860	0.308	0.648	0.866	0.652	0.661
	CR	0.764	0.934	0.671	0.776	0.932	0.382	0.770	0.935	0.775	0.780
		Low‐risk Prostate
${\mathrm{D}}_{98}$	M3D	0.559	0.585	0.466	0.555	0.585	0.435	0.556	0.590	0.547	0.549
	CC	0.415	0.541	0.337	0.415	0.541	0.315	0.416	0.541	0.409	0.414
	CR	0.549	0.646	0.464	0.556	0.646	0.425	0.554	0.646	0.558	0.562
${\mathrm{D}}_2$	M3D	0.701	0.691	0.626	0.700	0.691	0.596	0.700	0.694	0.698	0.697
	CC	0.402	0.539	0.281	0.397	0.539	0.249	0.398	0.539	0.389	0.392
	CR	0.700	0.758	0.590	0.703	0.758	0.540	0.702	0.758	0.703	0.705
${\mathrm{D}}_{50}$	M3D	0.853	0.858	0.756	0.851	0.857	0.719	0.852	0.862	0.846	0.846
	CC	0.530	0.882	0.320	0.531	0.882	0.262	0.531	0.882	0.525	0.532
	CR	0.856	0.956	0.711	0.860	0.955	0.648	0.859	0.957	0.861	0.864
		Prostate Bed
${\mathrm{D}}_{98}$	M3D	0.848	0.885	0.833	0.850	0.883	0.740	0.849	0.888	0.840	0.850
	CC	0.484	0.563	0.425	0.472	0.556	0.260	0.479	0.573	0.447	0.475
	CR	0.535	0.614	0.525	0.543	0.616	0.441	0.539	0.610	0.531	0.541
${\mathrm{D}}_2$	M3D	0.660	0.655	0.634	0.652	0.650	0.533	0.657	0.663	0.644	0.654
	CC	0.382	0.465	0.340	0.380	0.460	0.188	0.382	0.472	0.358	0.381
	CR	0.591	0.706	0.544	0.595	0.701	0.316	0.593	0.712	0.567	0.594
${\mathrm{D}}_{50}$	M3D	0.926	0.944	0.907	0.925	0.941	0.806	0.926	0.949	0.915	0.926
	CC	0.715	0.876	0.654	0.718	0.870	0.424	0.717	0.882	0.682	0.718
	CR	0.796	0.900	0.751	0.800	0.895	0.526	0.798	0.904	0.773	0.799

$\mathrm{M}3\mathrm{D}=\text{Mobius}3\mathrm{D}$; $\text{CC}=\text{COMPASS dose calculation}$; $\text{CR}=\text{COMPASS dose reconstruction}$; $\text{Poiss}=\text{Poisson}$; $\text{Sigm}=\text{sigmoidal}$; $\text{Niem}=\text{Niemierko}$.